RA-VII

• Description:

  RA-VII is an antitumor agent that exhibits significant activity against L1210, B-16 melanoma, Lewis lung carcinoma, Colon 38 and Ehrlich carcinoma[1].

• UNSPSC:

  12352209

• Target:

  Arp2/3 Complex

• Type:

  Peptides

• Related Pathways:

  Cytoskeleton

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/ra-vii.html

• Solubility:

  10 mM in DMSO

• Smiles:

  COC1=C2C=C(C[C@]3([H])N(C([C@](N(C([C@@H](NC([C@@H](N(C([C@@H](NC([C@H](NC3=O)C)=O)C)=O)C)CC4=CC=C(C=C4)OC)=O)C)=O)C)([H])CC5=CC=C(O2)C=C5)=O)C)C=C1

• Molecular Formula:

  C41H50N6O9

• Molecular Weight:

  770.87

• References & Citations:

  [1]Itokawa H, et al. Isolation and antitumor activity of cyclic hexapeptides isolated from Rubiae radix. Chem Pharm Bull (Tokyo) . 1984 Jan;32 (1) :284-90.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  [86229-97-2]